ConductScience.org, home

Paper57505

Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.

Pierides AM and 5 others. Lancet, 1976. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy. Papers, record 57505. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/57505

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
5.89
iCite
Revised in PubMed
2019-06-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pierides AMA M
2Ellis HAH A
3Simpson WW
4Dewar JHJ H
5Ward MKM K
6Kerr DND N

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydroxycholecalciferolsMajor topic
Osteitis Fibrosa CysticaMajor topic
OsteomalaciaMajor topic
Renal DialysisMajor topic
Alkaline Phosphatase
Biopsy
Calcium
Drug Evaluation
Female
Follow-Up Studies
Humans
Ilium
Male
Parathyroid Hormone
Phosphates
Time Factors
Uremia

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
7427411Serum concentrations of 24,25-dihydroxy vitamin D in different degrees of chronic renal failure.Br Med J1980https://conductscience.org/library/papers/7427411PubMed
6262039Pharmacology and therapeutic use of vitamin D and its analogues.Drugs1981https://conductscience.org/library/papers/6262039PubMed
922419Prediction of postdialysis hypophosphataemia.Br Med J1977https://conductscience.org/library/papers/922419PubMed
912593Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.Calcif Tissue Res1977https://conductscience.org/library/papers/912593PubMed
9125491alpha-Hydroxycholecalciferol in children with renal osteodystrophy.Calcif Tissue Res1977https://conductscience.org/library/papers/912549PubMed
9125111alpha-Hydroxycholecalciferol in renal osteodystrophy.Calcif Tissue Res1977https://conductscience.org/library/papers/912511PubMed
9122691-alpha-hydroxycholecalciferol for renal osteodystrophy.Br Med J1977https://conductscience.org/library/papers/912269PubMed
879833Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.Arch Dis Child1977https://conductscience.org/library/papers/879833PubMed
8798321,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.Arch Dis Child1977https://conductscience.org/library/papers/879832PubMed
871770Diseases of the urinary system. renal osteodystrophy.Br Med J1977https://conductscience.org/library/papers/871770PubMed
832019Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.Br Med J1977https://conductscience.org/library/papers/832019PubMed
700946Effects of 1alpha-hydroxyvitamin D3 on serum calcium and immunoreactive parathyroid hormone in patients with chronic renal insufficiency.Int Urol Nephrol1978https://conductscience.org/library/papers/700946PubMed
389958Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.J Clin Pathol1979https://conductscience.org/library/papers/389958PubMed
334342Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure.Calcif Tissue Res1977https://conductscience.org/library/papers/334342PubMed
228817Contrasting effects on bone formation and on fracture healing of cholecalciferol and of 1 alpha-hydroxycholecalciferol.Calcif Tissue Int1979https://conductscience.org/library/papers/228817PubMed
207382Clinical use of 1-alpha-hydroxyvitamin D3.Br Med J1978https://conductscience.org/library/papers/207382PubMed
21026Serum ionized calcium in renal failure --- a guideline for 1alpha-hydroxycholecalciferol treatment.Calcif Tissue Res1977https://conductscience.org/library/papers/21026PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/57505

GET https://conductscience.org/api/papers/v1/57505/authors